Pfizer and BioNTech announced Thursday they would seek authorization for a third dose of their COVID-19 vaccine to boost its efficacy, as the Delta variant drove...
Japan opened its first mass vaccination centres on Monday in a bid to speed up a cautious COVID-19 inoculation programme with just two months until the...
The Pfizer-BioNTech COVID-19 vaccine can be stored at refrigerator temperatures for up to a month in the United States, the country’s health regulator announced Wednesday, in...
The Pfizer and Moderna COVID vaccines should remain highly effective against two coronavirus variants first identified in India, according to new research carried out by US scientists....
The US Food and Drug Administration (FDA) on Monday authorized the use of the Pfizer-BioNTech COVID-19 vaccine for children aged 12 to 15 years old. Acting...
Moderna said Thursday its COVID-19 vaccine is 96 per cent effective among youths aged 12 to 17, according to the results of its first clinical trials....
The largest real-world study yet of the Pfizer/BioNTec vaccine on Thursday confirmed that the jab provided more than 95 per cent protection against COVID-19, but found...
The United States is expected to authorize the Pfizer-BioNTech COVID-19 vaccine for children age 12 and up by early next week, US media reported Monday. Pfizer...
The South African coronavirus variant is better at “breaking through” the defences of the Pfizer/BioNTech vaccine than other forms of the virus, Israeli experts said Sunday. However,...
Hong Kong will resume administering the Pfizer/BioNTech coronavirus jab on Monday after the pharma giant said a packaging flaw that temporarily halted its use did not affect...
